Mallinckrodt and Endo shareholders approve merger; Irish High Court sanction next

Keenova Therapeutics plc

All Mallinckrodt shareholder resolutions passed unanimously (100% for, 0 against) at Court and Extraordinary General Meetings.
Endo shareholders also approved the combination; deal is a stock-and-cash transaction.
Mallinckrodt to seek Irish High Court confirmation in July; closing targeted weeks after sanction hearing.
Post-closing, combined company plans to separate generic pharma and sterile injectables businesses at a later date.

item 5.07item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.